71320-77-9 Category:
  • #LGM Pharma is a Moclobemide CAS# 71320-77-9 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 71320-77-9
  • AHFC code: 28:16.04.12
  • Synonyms: 4-Chlor-N-(2-morpholinoethyl)benzamid 4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide 4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide Moclaime Moclamide Moclamine Moclobemid Moclobemida [INN-Spanish] Moclobemide [Usan:Ban:Inn] Moclobemidum [INN-Latin] p-Chloro-N-(2-morpholinoethyl)benzamide
  • ATC Code: N06AG02
  • Chemical Formula: C17H27NO4
  • Molecular Weight: 268.739
  • Assay/Purity: Typically NLT 98%
  • DrugBank: DB01171 (APRD00603)
  • PubChem: 4235
  • IUPAC: 4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide

Additional Details

For the treatment of depression.
Moclobemide belongs to a class of MAOI antidepressants known as reversible inhibitors of monoamine oxidase type-A (RIMAs). The primary role of monoamine oxidase MAO lies in the metabolism of and regulation of the levels of monoamines (serotonin, norepinephrine, and dopamine). Within neurons, MAO appears to regulate the levels of monoamines released upon synaptic firing. Since depression is associated with low levels of monoamines, the inhibition of MAO serves to ease depressive symptoms. RIMAs demonstrate transient inhibition of the substrate binding site of MAO-A as well as competitive displacement from this site by bioamines. The RIMAs are distinguished from the older monoamine oxidase inhibitors (MAOIs) by their selectivity and reversibility.
Mode of Action:
The mechanism of action of moclobemide involves the selective, reversible inhibition of MAO-A. This inhibition leads to a decrease in the metabolism and destruction of monoamines in the neurotransmitters. This results in an increase in the monoamines, relieving depressive symptoms.
Moclobemide is almost completely metabolized in the liver by Cytochrome P450 2C19 and 2D6.
LD50 (mouse) is 730mg/kg and LD50 (rat) is 1,300mg/kg. Signs of toxicity include hypertension, drowsiness, dizziness, confusion, tremors, headache, agitation, muscle rigidity and seizures.
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization


  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials


Related YouTube Videos